09:51 MASSIVE RES<00070> - Announcement & Resumption (10) in respect of the intended acquisition. In the event that the Acquisition cannot be completed, the HK$20 million from the net proceeds of the Subscription assigned for payment of the cash consideration of the Acquisition will be used in other investment(s) which have not yet been identified by the Group. The net proceeds raised per Subscription Shares will be about HK$0.0344 per Shares. The Company will bear an aggregate expenses and costs of about HK$2 million incurred in relation to the Placing and the Subscription. General mandate The Subscription Shares will be issued under the general mandate ("General Mandate") to allot, issue and deal with Shares granted to the Directors by resolution of the Shareholders passed at the annual general meeting (the "AGM") of the Company held on 30 November 2004 subject to the limit up to 20% of the issued share capital of the Company as at the date of passing the resolution at the AGM (i.e. 1,816,272,000 Shares). As at the date of this announcement, no Share has been issued under the General Mandate. CAPITAL RAISING ACTIVITIES OF THE COMPANY DURING THE PAST 12 MONTHS During the past 12 months, the capital raising activities of the Company include: Actual use of Discount/ proceeds as at premium to Intended use the date of Date of the market Net proceeds of net proceeds this announcement Announcement Event Placees price (Approximately) (Approximately) (Approximately) 4 March 2004 Open offer of N/A A discount of HK$87.8 million (i) About HK$14.1 million for (i) About HK$14.1 million 4,540,680,000 about 43.5% repayment of outstanding used for repayment of offer shares to the closing price debts and loans due to outstanding debts and at HK$0.02 of HK$0.023 per Independent Third Parties; loans due to Independent per offer share Share as quoted (ii) about HK$15.8 million Third Parties; with bonus issue on the Stock for redemption of the convertible (ii) about HK$15.8 million of 2,270,340,000 Exchange on notes issued in June 2003; used for redemption of bonus shares 26 February 2004 (iii) about HK$20.0 million for the convertible notes operating expenses of a subsidiary issued in June 2003; of the Company; (iii) about HK$20.0 million (iv) about HK$25.0 million for expansion for operating expenses of of the Group's business through a subsidiary of the Company intended acquisition in the field which has not yet of Chinese medicine and been utilized; health products; and (iv) the Company has not (v) remaining of about HK$12.9 million identified any suitable for general working capital. Chinese medicine and health products for expansion of the Group's business, in order to effectively utilize the Group's financial resources and maximize the Group's potential returns, the Board is considering to utilize the HK$20 million for payment of part of the consideration of the acquisition of 70% interest and 70% shareholder's loan in EC Link Pacific Limited as announced by the Company on 25 November 2004; and